BackClearPoint Neuro Overview
ClearPoint Neuro Inc

ClearPoint Neuro Target Price

Analysts' average 12-month price target for ClearPoint Neuro is $21.

Get informed when a big investor buys or sells

+ Follow

Share Price

$13.96

Average Target Price

$21.0050.4% upside

3 analysts in the last 4 months

High: $25 | Low: $16

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-04Lake Street$2579.1% upsideOpen
2026-08-04Stifel NicolausTom Stephan$2257.6% upsideOpen
2026-06-09Stifel NicolausTom Stephan$1614.6% upsideOpen
2025-01-21Lake StreetFrank Takkinen$30114.9% upsideOpen
2024-08-27Loop Capital MarketsFrank Takkinen$157.4% upsideOpen
2024-03-13Stifel NicolausMathew Blackman$935.5% downsideOpen

ClearPoint Neuro (CLPT) FAQ

ClearPoint Neuro posts a target price of $21. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $21 for CLPT means covering analysts, on average, see the stock 50.4% upside of $13.96 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for CLPT's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; ClearPoint Neuro's other metric pages and overview cover the third.

Judging ClearPoint Neuro against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $21 here, then scan peer and history charts to see if the gap is persistent.